Fisher et al. showed that ICAM-1 deficiency or blockade decreased CD8+ T cell infiltration into melanoma (B16-OVA) or colon carcinoma tumors (CT26), respectively, demonstrating ICAM-1 expression affecting T cell infiltration into tumors at least in certain tumor models (125). The gene discussed is ICAM1; the disease is neoplasm.